Helsinn Group
Enrico Magnani has a diverse work experience spanning over two decades. Enrico currently holds the position of Chief Strategy Officer at Helsinn Group since July 2023. Prior to this, they served as the General Manager at Helsinn Pharmaceuticals (Beijing) Co., Ltd. starting from July 2019.
Enrico joined Helsinn Group in 2010 and held various roles including Deputy Head of China Operations, Head of Commercial Development, China, and Global Product Manager. Enrico'stenure at Helsinn Group lasted from January 2010 to June 2019.
Before joining Helsinn Group, Enrico worked as an Engagement Manager at Novasecta from July 2006 to November 2010. Enrico also briefly served as a Research Associate at Library House in the same year.
Enrico's career began in 1999 as a Research Scientist at GlaxoSmithKline, where they worked until September 2001.
Enrico Magnani has a strong education history in both neuroscience and pharmacology. Enrico received their PhD in Neuroscience from the University of Cambridge between 2002 and 2005. In 1994-2000, they obtained a Laurea Cum Laude in Pharmacology from Alma Mater Studiorum – Università di Bologna. In 2013, they also pursued a short-term course in Finance for Senior Managers at the London Business School.
This person is not in any offices
Helsinn Group
1 followers
Welcome to Helsinn’s LinkedIn page. This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer supportive care and an innovative pipeline of cancer therapeutics. Helsinn is a third-generation family-owned company, that since 1976 has been focused on improving the lives of patients, guided by core values of respect, integrity and quality. It operates a unique licensing business model with integrated drug development and manufacturing capabilities. Helsinn has a commercial presence in 190 countries either directly, with operating subsidiaries in the U.S. and China, or via its long-standing trusted partners. Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd. If you are interested in joining Helsinn or one of our affiliates, please visit helsinn.com. Applications should only be submitted via the appropriate country portal under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact: Switzerland: info-HHC@helsinn.com, U.S.: HTU-HR@helsinn.com, Ireland: info-hbp@helsinn.com. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED]